![](/img/cover-not-exists.png)
Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials
Zhou, Jian-Guo, Huang, Lang, Jin, Su-Han, Xu, Cheng, Frey, Benjamin, Ma, Hu, Gaipl, Udo SVolume:
5
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2019-000621
Date:
February, 2020
File:
PDF, 1.23 MB
2020